Akari Therapeutics PLC (AKTX)
1.28
-0.19
(-12.93%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Market Cap: 15.30M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 17.57M |
| November 19, 2024 | 18.77M |
| November 18, 2024 | 27.37M |
| November 15, 2024 | 24.86M |
| November 14, 2024 | 26.66M |
| November 13, 2024 | 26.78M |
| November 12, 2024 | 27.49M |
| November 11, 2024 | 27.49M |
| November 08, 2024 | 29.29M |
| November 07, 2024 | 29.05M |
| November 06, 2024 | 27.67M |
| November 05, 2024 | 29.05M |
| November 04, 2024 | 29.04M |
| November 01, 2024 | 33.23M |
| October 31, 2024 | 28.69M |
| October 30, 2024 | 28.81M |
| October 29, 2024 | 29.88M |
| October 28, 2024 | 28.69M |
| October 25, 2024 | 28.26M |
| October 24, 2024 | 27.13M |
| October 23, 2024 | 26.42M |
| October 22, 2024 | 25.50M |
| October 21, 2024 | 25.82M |
| October 18, 2024 | 26.78M |
| October 17, 2024 | 26.42M |
| Date | Value |
|---|---|
| October 16, 2024 | 30.12M |
| October 15, 2024 | 30.49M |
| October 14, 2024 | 31.74M |
| October 11, 2024 | 32.27M |
| October 10, 2024 | 31.56M |
| October 09, 2024 | 35.26M |
| October 08, 2024 | 36.58M |
| October 07, 2024 | 36.28M |
| October 04, 2024 | 35.93M |
| October 03, 2024 | 35.86M |
| October 02, 2024 | 35.62M |
| October 01, 2024 | 35.86M |
| September 30, 2024 | 35.26M |
| September 27, 2024 | 35.14M |
| September 26, 2024 | 36.46M |
| September 25, 2024 | 37.77M |
| September 24, 2024 | 35.62M |
| September 23, 2024 | 38.25M |
| September 20, 2024 | 38.49M |
| September 19, 2024 | 37.77M |
| September 18, 2024 | 37.53M |
| September 17, 2024 | 39.69M |
| September 16, 2024 | 39.09M |
| September 13, 2024 | 38.91M |
| September 12, 2024 | 39.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.785M
Minimum
Apr 11 2024
149.28M
Maximum
Feb 19 2021
49.86M
Average
47.06M
Median
Market Cap Benchmarks
| DBV Technologies SA | 46.66M |
| Cellectis SA | 188.18M |
| Adaptimmune Therapeutics PLC | 162.23M |
| Biodexa Pharmaceuticals PLC | 2.532M |
| NuCana PLC | 2.853M |
Market Cap Related Metrics
| Price | 1.28 |
| Earnings Yield | -168.5% |